An old, dangerous drug has made a comeback with a new generation of users
NDEWS Co-Investigator Dr. Joseph Palamar discusses the re-emergence of gamma-hydroxybutyric acid (GHB) with NBC News in a new article.
All Posts
Nora’s Blog: NIDA researchers adapt their projects to study COVID-19
Dr. Nora Volkow, the Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health, describes the NDEWS COVID-19 supplement in her blog post. Read more about our initiative to track substance-use-related COVID-19 consequences through local key informant interviews in all 18 sentinel sites.
UF named coordinating center for national drug abuse surveillance system
This press release from UF Health provides an overview of the new National Drug Early Warning System (NDEWS), funded to UF by the National Institute on Drug Abuse (NIDA) in April 2020.
